Chemical basis of hashish activity.
Raphael Mechoulam, A Shani, H Edery, Y Grunfeld
Science August 7, 1970 DOI: 10.1126/science.169.3945.611 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Monkeys |
| Interventions | Delta(1)-tetrahydrocannabinol cannabinol cannabidiol cannabichromene cannabigerol cannabicyclol |
| Key findings | Delta(1)-tetrahydrocannabinol is the only major psychotomimetically active compound in hashish. |
Abstract
A sample of hashish was extracted consecutively with petroleum ether, benzene, and methanol. When tested intravenously in monkeys only the petroleum-ether fraction was active. This material was further fractionated. The only active compound isolated was Delta(1)-tetrahydrocannabinol. Cannabinol, cannabidiol, cannabichromene, cannabigerol, and cannabicyclol when administered together with Delta(1)-tetrahydrocannabinol do not cause a change in the activity of the latter, under the experimental conditions used. These results provide evidence that, except for Delta(1)-tetrahydrocannabinol, no other major, psychotomimetically active compounds are present in hashish.
Citations in the library
Cited by 17
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age Frontiers in Immunology September 21, 2018
- Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolescent Psychiatry April 1, 2013
- Medical Cannabis sativa (Marijuana or drug type): Psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC) International Journal of Research and Innovation in Applied Science 2023
- An emerging trend in Novel Psychoactive Substances (NPSs): designer THC Journal of Cannabis Research May 3, 2024
- Differential Enantiomer-Specific Signaling of Cannabidiol at CB1 Receptors. Molecular Pharmacology December 2022
and 12 more in the library